MicroRNAs in inflammation

International Reviews of Immunology

Volumn 28, Issue 6, 2009, Pages 535-561

  Sonkoly, Enikö ^a   Pivarcsi, Andor ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Immunity; Inflammation; Inflammatory diseases; MicroRNA

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BETA INTERFERON; BIM PROTEIN; CD209 ANTIGEN; CXCL2 CHEMOKINE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GAMMA INTERFERON; GENE PRODUCT; I KAPPA B KINASE EPSILON; INTERFERON REGULATORY FACTOR 4; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; RANTES; STAT1 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR RUNX1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; ASTHMA; AUTOIMMUNITY; B LYMPHOCYTE; CELL TYPE; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; MONOCYTE; NONHUMAN; OSTEOARTHRITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; ULCERATIVE COLITIS;

ANIMALS; GENE REGULATORY NETWORKS; HUMANS; IMMUNITY; INFLAMMATION; MICRORNAS;

EID: 71449107946     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830180903208303     Document Type: Review

References (97)

1. V. Ambros. microRNAs: Tiny regulators with great potential. Cell 107: 823-826, 2001.
2. R.C. Lee and V. Ambros. An extensive class of small RNAs in Caenorhabditis elegans. Science 294: 862-864, 2001.
3. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, and T. Tuschl. Identification of novel genes coding for small expressed RNAs. Science 294: 853-858, 2001.
4. N.C. Lau, L.P. Lim, E.G. Weinstein, and D.P. Bartel. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862, 2001.
5. D.P. Bartel. microRNAs: Target recognition and regulatory functions. Cell 136: 215-233, 2009.
6. M. Selbach, B. Schwanhausser, N. Thierfelder, et al.Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63, 2008.
7. D. Baek, J. Villen, C. Shin, et al. The impact of microRNAs on protein output. Nature 455: 64-71, 2008.
8. R.C. Friedman, K.K. Farh, C.B. Burge, and D.P. Bartel. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105, 2009.
9. A.M. Heimberg, L.F. Sempere, V.N. Moy, et al. microRNAs and the advent of vertebrate morphological complexity. Proc Natl Acad Sci U S A 105: 2946-2950, 2008.
10. A.E. Pasquinelli, B.J. Reinhart, F. Slack, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408: 86-89, 2000.
11. C.Z. Chen, L. Li, H.F. Lodish, and D.P. Bartel. microRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86, 2004.
12. J.F. Chen, E.M. Mandel, J.M. Thomson, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38: 228-233, 2006.
13. E. Sonkoly, T. Wei, P.C. Janson, et al. microRNAs: Novel regulators involved in the pathogenesis of psoriasis? PLoS ONE 2: e610, 2007.
14. R. Yi,M.N. Poy,M. Stoffel, and E. Fuchs. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452: 225-229, 2008.
15. J. Chang, E. Nicolas, D. Marks, et al. miR-122, a mammalian liver-specific microRNA is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 1: 106-113, 2004.
16. E. Sonkoly, M. Stahle, and A. Pivarcsi. microRNAs and immunity: Novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18: 131-140, 2008.
17. D. Catalucci,M.V. Latronico, andG. Condorelli. microRNAs control gene expression: Importance for cardiac development and pathophysiology. Ann N Y Acad Sci 1123: 20-29, 2008.
18. C. Xiao, L. Srinivasan, D.P. Calado, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9: 405-414, 2008.
19. A. Ventura, A.G. Young, M.M. Winslow, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132: 875-886, 2008.
20. V. Ambros. The functions of animal microRNAs. Nature 431: 350-355, 2004.
21. H.K. Saini, A.J. Enright, and S. Griffiths-Jones. Annotation of mammalian primary microRNAs. BMC Genomics 9: 564, 2008.
22. Y. Lee, C. Ahn, J. Han, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419, 2003.
23. G. Hutvagner, J. McLachlan, A.E. Pasquinelli, et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838, 2001.
24. E. Bernstein, A.A. Caudy, S.M. Hammond, and G.J. Hannon. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-366, 2001.
25. A. Grishok, A.E. Pasquinelli, D. Conte, et al. Genes andmechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106: 23-34, 2001.
26. J.R. Neilson, G.X. Zheng, C.B. Burge, and P.A. Sharp. Dynamic regulation ofmiRNA expression in ordered stages of cellular development. Genes Dev 21: 578-589, 2007.
27. C.Z. Chen and H.F. Lodish. microRNAs as regulators of mammalian hematopoiesis. Semin Immunol 17: 155-165, 2005.
28. R. Garzon and C.M. Croce. microRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 15: 352-358, 2008.
29. X. Zhou, J.G. Krueger, M.C. Kao, et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 13: 69-78., 2003.
30. C. Xiao, D.P. Calado, G. Galler, et al. miR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159, 2007.
31. Q.J. Li, J. Chau, P.J. Ebert, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161, 2007.
32. F. Fazi, S. Racanicchi, G. Zardo, et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 12: 457-466, 2007.
33. H.Wu, J.R. Neilson, P. Kumar, et al. miRNA profiling of naive, effector and memory CD8 T cells. PLoS ONE 2: e1020, 2007.
34. E. Sonkoly and A. Pivarcsi. Advances in microRNAs: Implications for immunity and inflammatory diseases. J Cell MolMed 13: 24-38, 2009.
35. M.A. Lindsay. microRNAs and the immune response. Trends Immunol 29: 343-351, 2008.
36. K.D. Taganov, M.P. Boldin, K.J. Chang, and D. Baltimore. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103: 12481-12486, 2006.
37. M.M. Perry, S.A. Moschos, A.E. Williams, et al. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol 180: 5689-5698, 2008.
38. J. Stanczyk, D.M. Pedrioli, F. Brentano, et al. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 58: 1001-1009, 2008.
39. T. Nakasa, S. Miyaki, A. Okubo, et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 58: 1284-1292, 2008.
40. K. Yamasaki, T. Nakasa, S. Miyaki, et al. Expression of microRNA-146a in osteoarthritis cartilage. Arthritis Rheum 60: 1035-1041, 2009.
41. S.A. Moschos, A.E. Williams, M.M. Perry, et al. Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics 8: 240, 2007.
42. E. Sonkoly,M. Stahle, and A. Pivarcsi. microRNAs: Novel regulators in skin inflammation. Clin Exp Dermatol 33: 312-315, 2008.
43. Y. Tang, X. Luo, H. Cui, et al. microRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60: 1065-1075, 2009.
44. K.M. Pauley, S. Cha, and E.K. Chan. microRNA in autoimmunity and autoimmune diseases. J Autoimmun 32: 189-194, 2009.
45. D. Iliopoulos, K.N. Malizos, P. Oikonomou, and A. Tsezou. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS ONE 3: e3740, 2008.
46. S.W. Jones, G. Watkins, N. Le Good, et al. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNFalpha and MMP13. Osteoarthritis Cartilage 17: 464-472, 2009.
47. A.E.Williams,M.M. Perry, S.A.Moschos, et al. Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans 36: 1211-1215, 2008.
48. J. Kluiver, S. Poppema, D. De Jong, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal, and diffuse large B cell lymphomas. J Pathol 207: 243-249, 2005.
49. R.M. O'Connell,D.S. Rao, A.A. Chaudhuri, et al. Sustained expression of microRNA- 155 in hematopoietic stem cells causes amyeloproliferative disorder.JExpMed205: 585-594, 2008.
50. N. Habbe, J.B. Koorstra, J.T. Mendell, et al. microRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther 8: 340-346, 2009.
51. A. Rodriguez, E. Vigorito, S. Clare, et al. Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611, 2007.
52. T.H. Thai, D.P. Calado, S. Casola, et al. Regulation of the germinal center response by microRNA-155. Science 316: 604-608, 2007.
53. H.F. Moffett and C.D. Novina. A small microRNA makes a Bic difference. Genome Biol 8: 221, 2007.
54. E. Vigorito, K.L. Perks, C. Abreu-Goodger, et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27: 847-859, 2007.
55. S. Kohlhaas, O.A. Garden, C. Scudamore, et al. Cutting edge: The Foxp3 target miR-155 contributes to the development of regulatory T cells. J Immunol 182: 2578-2582, 2009.
56. L.F. Lu, T.H. Thai, D.P. Calado, et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30: 80-91, 2009.
57. M.M. Chong, J.P. Rasmussen, A.Y. Rudensky, and D.R. Littman. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med 205: 2005-2017, 2008.
58. A. Liston, L.F. Lu, D. O'Carroll, et al. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J ExpMed 205: 1993-2004, 2008.
59. X. Zhou, L.T. Jeker, B.T. Fife, et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J ExpMed 205: 1983-1991, 2008.
60. B.S. Cobb, A. Hertweck, J. Smith, et al. A role for Dicer in immune regulation. J Exp Med 203: 2519-2527, 2006.
61. A. Marson, K. Kretschmer, G.M. Frampton, et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445: 931-935, 2007.
62. Y. Zheng, S.Z. Josefowicz, A. Kas, et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445: 936-940, 2007.
63. R.M. O'Connell, K.D. Taganov, M.P. Boldin, et al. microRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104: 1604-1609, 2007.
64. E. Tili, J.J. Michaille, A. Cimino, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179: 5082-5089, 2007.
65. M. Ceppi, P.M. Pereira, I. Dunand-Sauthier, et al. microRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci U S A 106: 2735-2740, 2009.
66. R.T. Martinez-Nunez, F. Louafi, P.S. Friedmann, and T. Sanchez-Elsner. microRNA- 155 modulates pathogen binding ability of dendritic cells by downregulation of DCspecific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem 284: 16334-16342, 2009.
67. L. He, J.M. Thomson, M.T. Hemann, et al. A microRNA polycistron as a potential human oncogene. Nature 435: 828-833, 2005.
68. Y. Hayashita, H. Osada, Y. Tatematsu, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005.
69. J.T. Mendell. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222, 2008.
70. L. Fontana, E. Pelosi, P. Greco, et al. microRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 9: 775-787, 2007.
71. Y. Dai, Y.S. Huang, M. Tang, et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16: 939-946, 2007.
72. M.L. Si, S. Zhu, H. Wu, et al. miR-21-mediated tumor growth. Oncogene 26: 2799-2803, 2007.
73. J.A. Chan, A.M. Krichevsky, and K.S. Kosik.microRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033, 2005.
74. S. Kohlhaas, O.A. Garden, C. Scudamore, et al. Cutting edge: The Foxp3 target miR-155 contributes to the development of regulatory T cells. J Immunol 182: 2578-2582, 2009.
75. L.F. Lu, T.H. Thai, D.P. Calado, et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30: 80-91, 2009.
76. M.M. Chong, J.P. Rasmussen, A.Y. Rudensky, and D.R. Littman. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med 205: 2005-2017, 2008.
77. A. Liston, L.F. Lu, D. O'Carroll, et al. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J ExpMed 205: 1993-2004, 2008.
78. X. Zhou, L.T. Jeker, B.T. Fife, et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J ExpMed 205: 1983-1991, 2008.
79. B.S. Cobb, A. Hertweck, J. Smith, et al. A role for Dicer in immune regulation. J Exp Med 203: 2519-2527, 2006.
80. A. Marson, K. Kretschmer, G.M. Frampton, et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445: 931-935, 2007.
81. Y. Zheng, S.Z. Josefowicz, A. Kas, et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445: 936-940, 2007.
82. R.M. O'Connell, K.D. Taganov, M.P. Boldin, et al. microRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104: 1604-1609, 2007.
83. E. Tili, J.J. Michaille, A. Cimino, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179: 5082-5089, 2007.
84. M. Ceppi, P.M. Pereira, I. Dunand-Sauthier, et al. microRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci U S A 106: 2735-2740, 2009.
85. R.T. Martinez-Nunez, F. Louafi, P.S. Friedmann, and T. Sanchez-Elsner. microRNA- 155 modulates pathogen binding ability of dendritic cells by downregulation of DCspecific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem 284: 16334-16342, 2009.
86. L. He, J.M. Thomson, M.T. Hemann, et al. A microRNA polycistron as a potential human oncogene. Nature 435: 828-833, 2005.
87. Y. Hayashita, H. Osada, Y. Tatematsu, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005.
88. J.T. Mendell. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222, 2008.
89. L. Fontana, E. Pelosi, P. Greco, et al. microRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 9: 775-787, 2007.
90. Y. Dai, Y.S. Huang, M. Tang, et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16: 939-946, 2007.
91. M.L. Si, S. Zhu, H. Wu, et al. miR-21-mediated tumor growth. Oncogene 26: 2799-2803, 2007.
92. J.A. Chan, A.M. Krichevsky, and K.S. Kosik.microRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033, 2005
93. C.J. Braun, X. Zhang, I. Savelyeva, et al. p53-Responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 68: 10094-10104, 2008.
94. F. Wu, M. Zikusoka, A. Trindade, et al. microRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 135: 1624-1635, 2008.
95. D. Yu, A.H. Tan, X. Hu, et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 450: 299-303, 2007.
96. C.G. Vinuesa, M.C. Cook, C. Angelucci, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435: 452-458, 2005.
97. K.A. Padgett, R.Y. Lan, P.C. Leung, et al. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun 32: 246-253, 2009.